Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366815426> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- W4366815426 abstract "Abstract Introduction: Burkitt's lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma (NHL) having three distinct subtypes: endemic, sporadic, and immunodeficiency-associated BL. Sporadic BL accounts for only 1 to 2% of adult NHL. Objectives: The objective of this article was to study the clinical profile and treatment outcome of patients with BL. Materials and Methods: This was a retrospective study of 60 patients with BL conducted in the department of medical oncology at a tertiary cancer center in India during a 10-year period. Patients with BL/leukemia above 14 years of age diagnosed during the study period were included and their clinical presentation, treatment details, and outcome were studied. Results: Among 60 cases with BL, there were 41 males and 19 females. The median age at presentation was 42 years (range: 14–81 years). The main symptoms were lymphadenopathy, abdominal pain, and abdominal distension. Two patients each had paraparesis, breast lump, and jaw swelling and one patient had involvement of the cervix. Thirteen patients had features of tumor lysis at presentation. The Ann Arbor stage was I in 17, II in 16, III in 5, and IV in 22. Fifty-five patients received combination chemotherapy that included hyper-cyclophosphamide, vincristine, adriamycin, dexamethasone ± rituximab (hyper-CVAD ± R; 35), cyclophosphamide, adriamycin, vincristine, prednisolone/ cyclophosphamide, vincristine, prednisolone ± rituximab CHOP ± R (13), Berlin-Frankfurt-Munich protocol (4), and others (3). Thirty-four patients attained remission, 13 patients had progressive disease, and 8 patients died during chemotherapy. At a median follow-up of 113 months, 58% patients were alive. Conclusions: BL accounts for 1.57% of NHL above the age of 14 years with male preponderance. Intensive, short-duration chemotherapy is the standard treatment. Treatment with hyper-CVAD ± R gives 8-year progression-free survival and overall survival (OS) of 60%. Treatment with CHOP ± R is an alternative option in elderly frail patients with an 8-year OS of 46%." @default.
- W4366815426 created "2023-04-25" @default.
- W4366815426 creator A5016354094 @default.
- W4366815426 creator A5022749052 @default.
- W4366815426 creator A5031310760 @default.
- W4366815426 creator A5059507909 @default.
- W4366815426 creator A5061876333 @default.
- W4366815426 creator A5071770976 @default.
- W4366815426 creator A5091360363 @default.
- W4366815426 date "2023-04-24" @default.
- W4366815426 modified "2023-10-18" @default.
- W4366815426 title "Treatment Outcome of Burkitt's Lymphoma in Adolescents and Adults: A Retrospective Study" @default.
- W4366815426 cites W1783838151 @default.
- W4366815426 cites W1819532763 @default.
- W4366815426 cites W1889566095 @default.
- W4366815426 cites W1961360814 @default.
- W4366815426 cites W1975280591 @default.
- W4366815426 cites W1978905721 @default.
- W4366815426 cites W1994482907 @default.
- W4366815426 cites W2001985588 @default.
- W4366815426 cites W2089921004 @default.
- W4366815426 cites W2106788175 @default.
- W4366815426 cites W2112539589 @default.
- W4366815426 cites W2121185379 @default.
- W4366815426 cites W2126232974 @default.
- W4366815426 cites W2128016135 @default.
- W4366815426 cites W2133201432 @default.
- W4366815426 cites W2144002645 @default.
- W4366815426 cites W2152291745 @default.
- W4366815426 cites W2157069955 @default.
- W4366815426 cites W2160009753 @default.
- W4366815426 cites W2495508741 @default.
- W4366815426 cites W2518731208 @default.
- W4366815426 cites W2884010291 @default.
- W4366815426 cites W3009742090 @default.
- W4366815426 cites W4255357812 @default.
- W4366815426 doi "https://doi.org/10.1055/s-0043-1768177" @default.
- W4366815426 hasPublicationYear "2023" @default.
- W4366815426 type Work @default.
- W4366815426 citedByCount "0" @default.
- W4366815426 crossrefType "journal-article" @default.
- W4366815426 hasAuthorship W4366815426A5016354094 @default.
- W4366815426 hasAuthorship W4366815426A5022749052 @default.
- W4366815426 hasAuthorship W4366815426A5031310760 @default.
- W4366815426 hasAuthorship W4366815426A5059507909 @default.
- W4366815426 hasAuthorship W4366815426A5061876333 @default.
- W4366815426 hasAuthorship W4366815426A5071770976 @default.
- W4366815426 hasAuthorship W4366815426A5091360363 @default.
- W4366815426 hasBestOaLocation W43668154261 @default.
- W4366815426 hasConcept C126322002 @default.
- W4366815426 hasConcept C141071460 @default.
- W4366815426 hasConcept C2776694085 @default.
- W4366815426 hasConcept C2776715498 @default.
- W4366815426 hasConcept C2776755627 @default.
- W4366815426 hasConcept C2779338263 @default.
- W4366815426 hasConcept C2779429289 @default.
- W4366815426 hasConcept C2779725641 @default.
- W4366815426 hasConcept C2780401358 @default.
- W4366815426 hasConcept C2780653079 @default.
- W4366815426 hasConcept C71924100 @default.
- W4366815426 hasConcept C90924648 @default.
- W4366815426 hasConceptScore W4366815426C126322002 @default.
- W4366815426 hasConceptScore W4366815426C141071460 @default.
- W4366815426 hasConceptScore W4366815426C2776694085 @default.
- W4366815426 hasConceptScore W4366815426C2776715498 @default.
- W4366815426 hasConceptScore W4366815426C2776755627 @default.
- W4366815426 hasConceptScore W4366815426C2779338263 @default.
- W4366815426 hasConceptScore W4366815426C2779429289 @default.
- W4366815426 hasConceptScore W4366815426C2779725641 @default.
- W4366815426 hasConceptScore W4366815426C2780401358 @default.
- W4366815426 hasConceptScore W4366815426C2780653079 @default.
- W4366815426 hasConceptScore W4366815426C71924100 @default.
- W4366815426 hasConceptScore W4366815426C90924648 @default.
- W4366815426 hasLocation W43668154261 @default.
- W4366815426 hasOpenAccess W4366815426 @default.
- W4366815426 hasPrimaryLocation W43668154261 @default.
- W4366815426 hasRelatedWork W160156331 @default.
- W4366815426 hasRelatedWork W1986069952 @default.
- W4366815426 hasRelatedWork W1991684338 @default.
- W4366815426 hasRelatedWork W2158035792 @default.
- W4366815426 hasRelatedWork W2171356556 @default.
- W4366815426 hasRelatedWork W2293389072 @default.
- W4366815426 hasRelatedWork W2343777302 @default.
- W4366815426 hasRelatedWork W2519696495 @default.
- W4366815426 hasRelatedWork W2920729066 @default.
- W4366815426 hasRelatedWork W2159407751 @default.
- W4366815426 isParatext "false" @default.
- W4366815426 isRetracted "false" @default.
- W4366815426 workType "article" @default.